Fig. 6
The Anti-proliferative activity IC50 (μg/mL) of BBL and BBT extracts on the DU-145, MCF-7, and Hep2c after 24 h of treatment. DU-145, prostate cancer cells; MCF-7; mammary cancer cells; Hep2c, human cervix carcinoma. BBL, B. bovei leaves; BBL, B. bovei corms; DOX, Doxorubicin. Data represented as Mean value ± SD of IC50 (μg/mL), inhibition concentration at which 50%. Significant antitumor actions notified from the MeOH of B. bovei leaves and corms against all three tested cell linens. Cytotoxic values for plant extracts were significantly different in compare to the reference Doxorubicin according to the Tukey’s honestly significant difference test at 5% significance level